Correction to: Cell Death Discovery (2017) 3, 16064; doi:10.1038/cddiscovery.2016.64; published online 6 February 2017
Since the publication of this article, it has been noted that the following acknowledgement was missing:
Mujib Ullah and Yasumasa Kuroda contributed equally to the work.
The authors apologise for this error.
The original html and pdf versions of the paper have been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/cddiscovery.2016.64
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Ullah, M., Kuroda, Y., Bartosh, T. et al. Erratum: iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers. Cell Death Discov. 3, 17029 (2017). https://doi.org/10.1038/cddiscovery.2017.29
Published:
DOI: https://doi.org/10.1038/cddiscovery.2017.29
This article is cited by
-
Tumor-homing Stem Cell Therapy for Brain Cancer
Current Surgery Reports (2017)
